We are adding PDCO as an active short into earnings scheduled for tomorrow morning. We'll start by apologizing for the last minute nature of this recommendation, but as we finished retooling our process, PDCO happens to be the first ticker out. We'll have more details out later today.
- PDCO screens short in our Quad Factor Scoring system, one of 34 tickers screening short of the 400+ tickers screened each week
- Signal Strength review singles out PDCO as a focus name from the group of short candidates
- Our fundamental review reveals several Health Care Macro and industry specific trackers that point to continued weakness into the second half of the fiscal year contrary guidance.
- Vet and dental distribution model is highly sensitive to modest changes in revenue assumptions and based on our below consensus EBITDA estimates we think shares can back into the $23-$24 range, and lower if the fundamental weakness extends into fiscal 2025
Please reach out to with any feedback or inquiries.
Have a great day out there!
Thomas Tobin
Managing Director
Twitter
LinkedIn
*Please note, not all Position Monitor names make it into the Quad Factor output - most likely due to a lack of sufficient historical trading and estimate data.
